CLEVELAND - The German-based manufacturer of the popular blood thinner Pradaxa will pay $650 million to approximately 4000 patients to settle injury lawsuits.
Boehringer Ingelheim says it settled the claims to "avoid the distraction and uncertainty of lengthy litigation."
Most patients complaints related to claims the company failed to adequately warn patients about the risk of internal bleeding.
In February, an exclusive NewsChannel5 investigation revealed Pradaxa is the most complained about drug in the United States.
Our research found more complaints were filed with the FDA about Pradaxa than any other prescription drug in both 2011 and 2012.
Since it was approved by the FDA in 2010, Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries, according to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices. The ISMP is a non-profit organization that monitors FDA reports.
Pradaxa is used to treat atrial fibrillation, a heart condition that significantly increases the risk of stroke.
Exclusive interview with crisis training expert
A nationally recognized crisis intervention training expert will play a key role as part of the independent monitor team selected to oversee…
2x killer pleads guilty in girlfriend's murder
A convicted killer who was the subject of a 5 on Your Side investigation after he was released from prison by the Ohio Parole Board has…
More records sought in CLE councilman probe
A second subpoena into possible ethics violations involving Cleveland City Councilman Joe Cimperman reveals the extent of records being…
FDA panel meeting on Essure safety concerns
Women affected by serious side effects after using Essure birth control testified at a day-long public meeting of the Food and…